Bank of Nova Scotia
IRWD icon

Bank of Nova Scotia’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bank of Nova Scotia’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-22,686
Closed -$299K – 948
2017
Q3 		$299K Sell
22,686
-16,743
-42% -$230K ﹤0.01% 876
2017
Q2 		$623K Hold
39,429
– – ﹤0.01% 835
2017
Q1 		$563K Sell
39,429
-121,788
-76% -$1.67M ﹤0.01% 807
2016
Q4 		$2.06M Buy
+161,217
New +$2.04M 0.01% 383

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Nova Scotia's IRWD Position: Q4 2017 in Review

Bank of Nova Scotia sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2017, closing a stake of 22,686 shares — an estimated $299K sold.

Bank of Nova Scotia first reported a position in IRWD in Q4 2016 and held it in 4 quarters. The position peaked at $2.06M in Q4 2016. 158 funds tracked by Wall St. Rank hold IRWD as of Q4 2017.

  • Bank of Nova Scotia reported no remaining Ironwood Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Bank of Nova Scotia sold 22,686 Ironwood Pharmaceuticals shares in Q4 2017, an estimated $299K.
  • Bank of Nova Scotia first reported a position in Ironwood Pharmaceuticals in Q4 2016 and held it in 4 quarters.
  • Bank of Nova Scotia's Ironwood Pharmaceuticals position peaked at $2.06M in Q4 2016.
  • 158 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2017.

Based on Bank of Nova Scotia's 13F filing for Q4 2017, filed 14 Feb 2018.